Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Court rules in favor of Novopharm regarding generic ranitidine product

April 7, 1997

FDA clears Faulding's generic captopril

April 7, 1997

Shire's sustained-release carbamazepine deemed approvable by FDA

April 4, 1997

Budesonide cleared in Canada for Crohn's disease

April 4, 1997

Digital Gene Technologies and Recordati collaborate on atherosclerosis research

April 4, 1997

New indication for liquid Nutropin approved by FDA

April 4, 1997

New epilepsy option approved in the U.S.

April 2, 1997

FDA tentatively approves generic acyclovir

April 2, 1997

Cytogen's Quadramet approved by FDA

April 1, 1997

Syrup formulation of Zofran available in the U.K.

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...